Deterioration of previous acute lung injury during neutropenia recovery

被引:107
作者
Azoulay, E [1 ]
Darmon, M
Delclaux, C
Fieux, F
Bornstain, C
Moreau, D
Attalah, H
Le Gall, JR
Schlemmer, B
机构
[1] St Louis Univ Hosp, Med Intens Care Unit, Paris, France
[2] Univ Paris 07, Paris, France
[3] U492 INSERM, Creteil, France
[4] CHU Henri Mondor, Physiol & Funct Testing Unit, F-94010 Creteil, France
关键词
cancer patients; acute respiratory distress syndrome; mechanical ventilation; leukemia; lymphoma; myeloma; solid tumors; neutropenia; neutropenia recovery; pneumonia; granulocyte colony-stimulating factor;
D O I
10.1097/00003246-200204000-00010
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Design: Although neutropenia recovery is associated with a high risk of deterioration of respiratory condition, no studies designed to identify risk factors for acute respiratory distress syndrome (ARDS) in this situation have been published. Setting: Medical ICU in a French teaching hospital. Subjects: We conducted a study to describe critically ill cancer patients with ARDS during neutropenia recovery (defined as the 7-day period centered on the day the neutrophil count rose above 1000/mm(3) [day 0]) and to compare them with critically ill cancer patients without ARDS during neutropenia recovery. Interventions: None. Measurements and Main Results: During a 10-yr period, 62 critically ill cancer patients recovered from neutropenia, of whom 21 experienced ARDS during neutropenia recovery, with a median time of -1 days (-2.5-1) between day 0 and ARDS. In-ICU mortality in these 21 patients was 61.9%. As compared with non-ARDS patients, ARDS patients were less likely to have myeloma and more likely to have leukemia/lymphoma treated with adriamycin, a history of pneumonia before neutropenia, and a neutropenia duration >10 days; they had a shorter time since malignancy diagnosis and a longer time from chemotherapy to neutropenia. Neither the leukocyte counts on day 0 nor those during the 6-day neutropenia recovery period were predictive of ARDS. Conclusions: Patients with acute respiratory failure after prolonged neutropenia complicated by pneumonia are at increased risk for ARDS. (Crit Care Med 2002; 30:781-786).
引用
收藏
页码:781 / 786
页数:6
相关论文
共 46 条
  • [1] USE OF BRONCHOALVEOLAR LAVAGE IN THE EVALUATION OF METHOTREXATE LUNG-DISEASE
    AKOUN, GM
    MAYAUD, CM
    TOUBOUL, JL
    DENIS, MF
    MILLERON, BJ
    PERROT, JY
    [J]. THORAX, 1987, 42 (09) : 652 - 655
  • [2] Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support
    Azoulay, E
    Alberti, C
    Bornstain, C
    Leleu, G
    Moreau, D
    Recher, C
    Chevret, S
    Le Gall, JR
    Brochard, L
    Schlemmer, B
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (03) : 519 - 525
  • [3] Changing use of intensive care for hematological patients: the example of multiple myeloma
    Azoulay, E
    Recher, C
    Alberti, C
    Soufir, L
    Leleu, G
    Le Gall, JR
    Fermand, JP
    Schlemmer, B
    [J]. INTENSIVE CARE MEDICINE, 1999, 25 (12) : 1395 - 1401
  • [4] Changes in the inflammatory response of the lung during acute respiratory distress syndrome: Prognostic indicators
    Baughman, RP
    Gunther, KL
    Rashkin, MC
    Keeton, DA
    Pattishall, EN
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (01) : 76 - 81
  • [5] Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
    Bhalla, KS
    Wilczynski, SW
    Abushamaa, AM
    Petros, WP
    McDonald, CS
    Loftis, JS
    Chao, NJ
    Vredenburgh, JJ
    Folz, RJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (01) : 17 - 25
  • [6] ALVEOLAR HEMORRHAGE - DIAGNOSTIC-CRITERIA AND RESULTS IN 194 IMMUNOCOMPROMISED HOSTS
    DELASSENCE, A
    FLEURYFEITH, J
    ESCUDIER, E
    BEAUNE, J
    BERNAUDIN, JF
    CORDONNIER, C
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (01) : 157 - 163
  • [7] DeMagalhaesSilverman M, 1996, BONE MARROW TRANSPL, V17, P329
  • [8] RISKS OF RHG-CSF TREATMENT IN DRUG-INDUCED AGRANULOCYTOSIS
    DEMUYNCK, H
    ZACHEE, P
    VERHOEF, GEG
    SCHETZ, M
    VANDENBERGHE, G
    LAUWERS, P
    BOOGAERTS, MA
    [J]. ANNALS OF HEMATOLOGY, 1995, 70 (03) : 143 - 147
  • [9] INTERLEUKIN-8 AND DEVELOPMENT OF ADULT RESPIRATORY-DISTRESS SYNDROME IN AT-RISK PATIENT GROUPS
    DONNELLY, SC
    STRIETER, RM
    KUNKEL, SL
    WALZ, A
    ROBERTSON, CR
    CARTER, DC
    GRANT, IS
    POLLOK, AJ
    HASLETT, C
    [J]. LANCET, 1993, 341 (8846) : 643 - 647
  • [10] GOLDSBERRY DT, 1993, NEW HORIZONS, V2, P342